Jasper Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 1.49 M | $31.95 M | 11.22% | 10.25% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 02/14/2025 | 1.43 M | $30.66 M | 0.00% | 9.83% |
| CARLYLE GROUP INC. | 02/13/2025 | 1.07 M | $22.67 M | 0.00% | 7.31% |
| QIMING U.S. VENTURES MANAGEMENT, LLC | 01/28/2025 | 928,964 | $19.86 M | 0.00% | 6.37% |
| BLACKROCK, INC. | 02/07/2025 | 808,086 | $17.28 M | 1.01% | 5.54% |
| BRAIDWELL LP | 02/14/2025 | 714,658 | $15.28 M | 47.87% | 4.90% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 650,000 | $13.90 M | 85.71% | 4.46% |
| SAMSARA BIOCAPITAL, LLC | 02/14/2025 | 584,642 | $12.50 M | 0.00% | 4.01% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 579,636 | $12.39 M | 0.00% | 3.97% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 463,088 | $9.90 M | 0.87% | 3.18% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 02/14/2025 | 447,000 | $9.56 M | -10.06% | 3.06% |
| CITADEL ADVISORS LLC | 02/14/2025 | 423,610 | $9.06 M | 199.24% | 2.90% |
| OPALEYE MANAGEMENT INC. | 02/14/2025 | 400,000 | $8.55 M | 13.15% | 2.74% |
| FMR LLC | 02/13/2025 | 388,523 | $8.31 M | 912.81% | 2.66% |
| 02/14/2025 | 350,000 | $7.48 M | 100.00% | 2.40% | |
| GREAT POINT PARTNERS LLC | 02/14/2025 | 322,380 | $6.89 M | 0.00% | 2.21% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 287,204 | $6.14 M | -11.87% | 1.97% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 257,687 | $5.51 M | 0.11% | 1.77% |
| WOODLINE PARTNERS LP | 02/14/2025 | 245,676 | $5.25 M | -50.38% | 1.68% |
| STATE STREET CORP | 02/14/2025 | 230,306 | $4.92 M | 7.18% | 1.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/14/2025 | 135,720 | $2.90 M | -28.29% | 0.93% |
| STEMPOINT CAPITAL LP | 02/14/2025 | 135,244 | $2.89 M | 100.00% | 0.93% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 122,600 | $2.62 M | 100.00% | 0.84% |
| ALLY BRIDGE GROUP (NY) LLC | 02/14/2025 | 122,424 | $2.62 M | -69.35% | 0.84% |
| NORTHERN TRUST CORP | 02/14/2025 | 104,367 | $2.23 M | -2.41% | 0.72% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 83,417 | $1.78 M | 0.00% | 0.57% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 82,165 | $1.76 M | 100.00% | 0.56% |
| MARSHALL WACE, LLP | 02/13/2025 | 77,722 | $1.66 M | 17.18% | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/14/2025 | 77,500 | $1.66 M | 100.00% | 0.53% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 65,000 | $1.39 M | 100.00% | 0.45% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/14/2025 | 61,100 | $1.31 M | 0.00% | 0.42% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/12/2025 | 59,034 | $1.24 M | 100.00% | 0.40% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 55,107 | $1.18 M | -0.12% | 0.38% |
| FERNWOOD INVESTMENT MANAGEMENT, LLC | 02/13/2025 | 52,897 | $1.13 M | 0.00% | 0.36% |
| MARINER, LLC | 02/13/2025 | 36,794 | $786,656 | -12.82% | 0.25% |
| LION POINT CAPITAL, LP | 02/14/2025 | 32,000 | $684,160 | 0.00% | 0.22% |
| JEFFERIES FINANCIAL GROUP INC. | 02/27/2025 | 31,250 | $668,125 | 100.00% | 0.21% |
| PALO ALTO INVESTORS LP | 02/14/2025 | 30,651 | $655,318 | 100.00% | 0.21% |
| SOWELL FINANCIAL SERVICES LLC | 02/07/2025 | 28,043 | $599,559 | 100.00% | 0.19% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 27,069 | $578,736 | 13.93% | 0.19% |
| ALLOSTERY INVESTMENTS LP | 02/14/2025 | 22,000 | $470,360 | 100.00% | 0.15% |
| SIMPLIFY ASSET MANAGEMENT INC. | 02/11/2025 | 20,000 | $427,600 | 100.00% | 0.14% |
| PROPEL BIO MANAGEMENT, LLC | 02/14/2025 | 20,000 | $427,600 | 100.00% | 0.14% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 17,979 | $384,391 | 6.98% | 0.12% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 16,800 | $359,184 | 100.00% | 0.12% |
| VERITION FUND MANAGEMENT LLC | 02/14/2025 | 15,050 | $321,769 | -40.64% | 0.10% |
| RHUMBLINE ADVISERS | 01/30/2025 | 14,761 | $315,581 | 12.60% | 0.10% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 13,853 | $296,177 | 13.22% | 0.10% |
| STATE OF WISCONSIN INVESTMENT BOARD | 02/14/2025 | 13,724 | $293,419 | 100.00% | 0.09% |
| CITADEL ADVISORS LLC | 02/14/2025 | 12,800 | $273,664 | 700.00% | 0.09% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Jasper Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 68 institutional investors and hedge funds held shares of Jasper Therapeutics, Inc.. The most heavily invested institutionals were:
Soleus Capital Management, L.P.: 1.49 M
Velan Capital Investment Management LP: 1.43 M
Carlyle Group Inc.: 1.07 M
Qiming U.S. Ventures Management, LLC: 928,964
BlackRock, Inc.: 808,086
BRAIDWELL LP: 714,658
107.28% of Jasper Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 19.87 M shares in the last 24 months. This purchase volume represents approximately $82.66 M in transactions.